These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Altered dopaminergic modulation of prolactin and aldosterone secretion in pseudohypoparathyroidism. Sowers JR; Brickman AS; Asp N; Tuck ML; Jasberg K; Magnone S J Clin Endocrinol Metab; 1981 May; 52(5):914-8. PubMed ID: 7014587 [TBL] [Abstract][Full Text] [Related]
3. Influence of sodium homeostasis on dopaminergic modulation of aldosterone, renin, and prolactin secretion in man. Sowers JR; Glub MS; Eggena PH; Catania RA J Clin Endocrinol Metab; 1982 Jan; 54(1):121-6. PubMed ID: 7033264 [TBL] [Abstract][Full Text] [Related]
4. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone. Carey RM; Thorner MO; Ortt EM J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333 [TBL] [Abstract][Full Text] [Related]
6. Effect of upright posture on the aldosterone responses to dopamine, metoclopramide, angiotensin II, and adrenocorticotropin. Malchoff CD; Hughes JM; Carey RM J Clin Endocrinol Metab; 1987 Jul; 65(1):203-7. PubMed ID: 3034955 [TBL] [Abstract][Full Text] [Related]
7. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine. Carey RM; Thorner MO; Ortt EM J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305 [TBL] [Abstract][Full Text] [Related]
8. The effect of metoclopramide and dopamine on plasma aldosterone concentration in normal man and rhesus monkeys (Macaca mulatta): a new model to study dopamine control of aldosterone secretion. Brown RD; Billman GE; Kem DC; Stone HL; Jiang NS; Kao P; Hegstad RL J Clin Endocrinol Metab; 1982 Nov; 55(5):828-32. PubMed ID: 7119085 [TBL] [Abstract][Full Text] [Related]
9. Dopamine control of aldosterone secretion in end-stage renal failure. GarcĂa-Robles R; Ruilope L; Tovar J; de Villa LF; Miranda B; Prieto C; Parada J; Sancho J; Rodicio JL Rev Esp Fisiol; 1986 Jun; 42(2):257-63. PubMed ID: 3092288 [TBL] [Abstract][Full Text] [Related]
10. Dopaminergic modulation of aldosterone secretion in the rhesus monkey: evidence that dopamine affects the late pathway of aldosterone biosynthesis by inhibiting the conversion of corticosterone to 18-hydroxycorticosterone. Sowers JR; Berg G; Martin VS; Mayes DM Endocrinology; 1982 Apr; 110(4):1173-7. PubMed ID: 7060520 [TBL] [Abstract][Full Text] [Related]
11. Effect of metoclopramide and domperidone on aldosterone, 18-hydroxycorticosterone and prolactin secretion in the rhesus monkey. Sowers JR; Eggena P; Phillips D Metabolism; 1982 Dec; 31(12):1219-23. PubMed ID: 7144566 [TBL] [Abstract][Full Text] [Related]
12. Acute dopaminergic inhibition of aldosterone secretion is independent of angiotensin II and adrenocorticotropin. Carey RM J Clin Endocrinol Metab; 1982 Feb; 54(2):463-9. PubMed ID: 6274907 [TBL] [Abstract][Full Text] [Related]
13. Effects of bromocriptine on renin, aldosterone, and prolactin responses to posture and metoclopramide in idiopathic edema: possible therapeutic approach. Sowers J; Catania R; Paris J; Tuck M J Clin Endocrinol Metab; 1982 Mar; 54(3):510-6. PubMed ID: 7035482 [TBL] [Abstract][Full Text] [Related]
14. Dopaminergic modulation of aldosterone responsiveness to angiotensin II with changes in sodium intake. Gordon MB; Moore TJ; Dluhy RG; Williams GH J Clin Endocrinol Metab; 1983 Feb; 56(2):340-5. PubMed ID: 6822640 [TBL] [Abstract][Full Text] [Related]
15. Dopaminergic modulation of aldosterone secretion in the normal menstrual cycle. Garcia-Robles R; Ruilope LM; Tovar J; de Pablos P; Parada J; Hurtado A; Miranda B; Fernandez Vazquez G; Rodicio JL; Sancho J J Clin Hypertens; 1987 Dec; 3(4):470-8. PubMed ID: 3134515 [TBL] [Abstract][Full Text] [Related]
16. Dopaminergic modulation of aldosterone secretion in the rat. Aguilera G; Catt KJ Endocrinology; 1984 Jan; 114(1):176-81. PubMed ID: 6317344 [TBL] [Abstract][Full Text] [Related]
17. [The effect of dopaminergic antagonists on plasma aldosterone in normal subjects and patients with hypopituitarism]. Shikuma R; Yoshimura M; Takashina R; Yamazaki H; Kambara S; Ijichi H Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1041-5. PubMed ID: 6394371 [TBL] [Abstract][Full Text] [Related]
18. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism. Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781 [TBL] [Abstract][Full Text] [Related]
19. Modulation of corticosteroid secretion by dopaminergic mechanisms in rhesus monkeys. Sowers JR Am J Physiol; 1982 Nov; 243(5):E375-9. PubMed ID: 7137342 [TBL] [Abstract][Full Text] [Related]
20. Role of prolactin and the renin-angiotensin system in mediating dopaminergic control of aldosterone secretion in the rat. Sowers JR; Golub M; Tuck M; Sowers DK Clin Exp Hypertens (1978); 1981; 3(1):1-14. PubMed ID: 7472089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]